FDA Panel Rejects Mirabel’s Bioimpedance Device For Breast Scanning
This article was originally published in The Gray Sheet
Executive Summary
FDA's Obstetrics & Gynecology Devices Panel voted unanimously not to recommend approval of Mirabel Medical Systems' T-Scan 2000 ED bioimpedance device at an Aug. 29 meeting in Gaithersburg, Md
You may also be interested in...
IoM Breast Cancer Detection Report Promotes Mammography Adjunct Tools
Widespread adoption of digital mammography for breast cancer detection will hinge on results from the National Cancer Institute's large trial comparing the technology with film screening, according to lead investigator Etta Pisano, MD, University of North Carolina at Chapel Hill
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.